SHMT2 plays a distinct and pivotal role in thyroid cancer progression, particularly in ATC, where its expression is significantly upregulated compared with PTC and normal thyroid tissue (Lee et al., 2024b). The gene discussed is SHMT2; the disease is thyroid cancer.